Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: GENE THERAPY FOR WISKOTT-ALDRICH SYNDROME IN A SEVERELY AFFECTED ADULT

PROVIDER: PRJNA387194 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5578660_1.fastq.gz	Fastqsanger.gz
	SRR5578660_2.fastq.gz	Fastqsanger.gz
	SRR5578670_1.fastq.gz	Fastqsanger.gz
	SRR5578670_2.fastq.gz	Fastqsanger.gz
	SRR5578680_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

Project description:Skin microbiome of Wiskott-Aldrich Syndrome

| PRJNA790974 | ENA

A novel WASP splice-site mutation in a patient with Wiskott-Aldrich syndrome

Project description:gene panel of patient with Wiskott-Aldrich syndrome

| PRJEB75037 | ENA

Next generation sequencing to determine DNA-binding sites of Wiskott-Aldich Syndrome Protein (WASP) in the cell line GM 11518 (wild-type) and in the cell line ID00003/WASP-c-EOS (WASP overexpressed)

Project description:To determine the global gene occupancy by Wiskott - Aldrich syndrome Protein (WASP) we perform ChIP-seq assay in two lymphoblastoid cell lines. We identify WASP-enriched genes, including several WASP-interaction genes previously reported; in addition, our results suggest the implication of WASP in diverse cellular process

2022-04-18 | GSE126483 | GEO

Project description:Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome, archive 1 of 2

| PRJNA782743 | ENA

Germinal Center B-Cell gene expression comparison between Wiskott-Aldrich syndrome protein KO mice and WT mice

Project description:This experiment intended to define differential gene expression between germinal center B cells expressing or not the Wiskott-Aldrich syndrome protein in mice. Sequencing was obtained on an Illumina HiSeq2500 system from Dark Zone GCB (DAPI-CD19+ GL7+IgD-CXCR4highCD86low) purified from CTL and GCBcWKO mice (n=4).

2021-06-01 | E-MTAB-10056 | biostudies-arrayexpress

Proteome quantification in WASP wild-type and deficient macrophages using DIA-MS

Project description:We knocked out Wiskott-Aldrich Syndrome protein (WASP) in an iPSC line and derived the cells to differentiate into macrophages. We found deficiency of WASP results in overexpression of splicing factors and irregulaly sized nulcear speckles. We performed DIA-MS based quantative proteome analysis for WASP wild-type and deficient macrophages.

2022-04-21 | PXD033326 | Pride

Project description:Targeted Integration Editing Approach for Correction of the Wiskott-Aldrich Syndrome

| PRJNA805265 | ENA

Transcription profiling of bone marrow derived mast cells from WASP negative and wild type mice to investigate the role of WASP in Kit signalling

Project description:The pleiotropic RTK Kit can provide cytoskeletal signals that define cell shape, positioning and migration, but the underlying mechanisms are less well understood. Here we provide evidence that Kit signals through WASP (Wiskott-Aldrich Syndrome Protein), the central hematopoietic actin nucleation- promoting factor and regulator of the cytoskeleton. KL-mediated gene expression in WT and WASP-deficient BMMCs was compared and revealed that approximately 30% of all Kit-induced changes were WASP-dependent. The results indicate that Kit signaling through WASP is necessary for normal Kit-mediated filopodia formation, cell survival and gene expression and provide new insight in the mechanism how WASP exerts a strong selective pressure in hematopoiesis.

2009-08-29 | E-MEXP-2282 | biostudies-arrayexpress

Wiskott-Aldrich Syndrome-causative mutations disrupt alternative splicing and promote gene networks predisposed to hematologic malignancies

Project description:Wiskott-Aldrich Syndrome-causative mutations disrupt alternative splicing and promote gene networks predisposed to hematologic malignancies

| PRJNA309863 | ENA

Homo sapiens

Project description:Wiskott-Aldrich Syndrome-causative mutations disrupt alternative splicing and promote gene networks predisposed to hematologic malignancies

| PRJNA309524 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data